Stock Upgrades, Downgrades From TheStreet.com Ratings
Each weekday, TheStreet.com Ratings updates its ratings on the stocks it covers. The proprietary ratings model projects a stock's total return potential over a 12-month period, including both price appreciation and dividends. Buy, hold or sell ratings designate how the Ratings group expects these stocks to perform against a general benchmark of the equities market and interest rates.
While the ratings model is quantitative, it uses both subjective and objective elements. For instance, subjective elements include expected equities market returns, future interest rates, implied industry outlook and company earnings forecasts. Objective elements include volatility of past operating revenue, financial strength and company cash flows.
TheStreet.com Ratings has initiated coverage of biotech firm Bionovo (BNVI) with a sell rating. The company develops drugs to treat breast and ovarian cancers, and for menopause. The company's losses continue to grow -- Bionovo lost 5 cents per share in the first quarter of fiscal 2007 after losing 2 cents per share in the same quarter a year earlier. Net operating cash flow was down 42.3% during that same time period.
TheStreet.com Ratings has initiated coverage of paper and packaging producer KapStone (KPPC) with a hold rating. The company made dramatic gains in earnings per share during the first quarter, when EPS rose to 21 cents per share from just 2 cents per share a year earlier. Investors reacted to KapStone's improved performance by pushing the stock price up 34.3% over the past 12 months. At the same time, TheStreet.com Ratings feels that profit margins remain lower than what is desirable. The company's gross profit margin is just 26.5%, while the net profit margin of 10.8% trails the industry average.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV